Hygienisation 8in1 for 329 PLN – take care of your dental health at an exceptional price!

The offer is valid for MediClub members.

1500 visits available 1500 visits available
 3788 doctors 3788 doctors
1800 blood tests and services 1800 blood tests and services
Verified opinions Verified opinions
Mediclub

Colotect – an alternative to colonoscopy

A non-invasive test from a stool sample to detect colorectal cancer tumours at an early stage. Fast, convenient and safe.

Buy cheaper - join MediClub and pay 5% less.

City
City
Supplier
Supplier
Sort by
Sort by

Medicover

from PLN 630.00 Mediclub logo Mediclub logo from PLN 598.50
The price includes all fees
Lowest price from 30 days before discounting PLN 598.50
  • Test description
  • Important information
  • Documents
Test description

Colotect

Colotect is a non-invasive epigenetic test that detects cancerous changes in the colon at an early stage. Colotect tests for up to three genes that are strongly associated with the development of colorectal cancer: SDC2, ADHFE1 and PPP2R5C. The high sensitivity and specificity of this test make it an excellent alternative to the traditional screening test: colonoscopy.

Why should you choose the Colotect test?

The test can detect colorectal cancer and precancerous lesions at an early stage, before they have a chance to develop into malignant cancer. The result of the Colotect test will be interpreted by a doctor.

badania krwi

The Colotect test:

  • is fast, simple and non-invasive;
  • has a high sensitivity (96%);
  • no need for any special preparation or a break in taking medicines;
  • performed on a sample taken by the patient at home;
  • safety: no contraindications or complications.

Who is it for?

The Colotect test is particularly suitable for individuals:

  • who are under 50 years of age and who are not yet eligible for colonoscopy and who have factors that increase the risk of bowel cancer (e.g. presence of polyps in the colon, inflammatory bowel disease, positive family history of bowel cancer, genetic conditions);
  • with contraindications to colonoscopy;
  • who report poor tolerance to previous colonoscopy;
  • with fear of colonoscopy.

The Colotect test should be repeated every 3 years.

Colorectal cancer is the third most commonly diagnosed cancer worldwide. The number of colo-rectal cancer cases has been increasing for years, even among young people. Every year in Poland there are about 20,000 new cases of this cancer and 12,000 people die from it.

Colorectal cancer is usually diagnosed at a late stage, when treatment options are limited. This is why regular screening is so important. Early diagnosis of colorectal cancer significantly increases the chances of effective treatment.

Important information
Documents